EQ - Equillium, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
La Jolla,
United States
Type: Equity
EQ price evolution
EQ
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $23.22 | $34.38 | $25.62 | $24.5 |
| Short term investments | $17.65 | $11.92 | $22.75 | $37.49 |
| Net receivables | $3.73 | $3.77 | $3.74 | $3.42 |
| Inventory | ||||
| Total current assets | $49.35 | $53.91 | $57.36 | $70.22 |
| Long term investments | ||||
| Property, plant & equipment | $1.11 | $1.24 | $1.32 | $1.47 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.18 | $1.31 | $1.41 | $1.57 |
| Total investments | $17.65 | $11.92 | $22.75 | $37.49 |
| Total assets | $50.53 | $55.23 | $58.76 | $71.79 |
| Current liabilities | ||||
| Accounts payable | $4.71 | $3.63 | $3.03 | $5.69 |
| Deferred revenue | $15.73 | $18.25 | $20.2 | $22.71 |
| Short long term debt | $0.44 | $0.43 | $0.42 | $6.12 |
| Total current liabilities | $27.57 | $28.2 | $25.22 | $32.02 |
| Long term debt | $0.38 | $0.5 | $0.61 | $2.56 |
| Total noncurrent liabilities | $0.38 | $2.92 | $6.57 | $10.5 |
| Total debt | $0.82 | $0.93 | $1.02 | $8.68 |
| Total liabilities | $27.96 | $31.12 | $31.78 | $42.52 |
| Shareholders' equity | ||||
| Retained earnings | -$185.74 | -$183.4 | -$179.69 | -$176.34 |
| Other shareholder equity | $0.14 | $0.46 | $0.34 | $0.3 |
| Total shareholder equity | $22.57 | $24.11 | $26.98 | $29.27 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $23.22 | $59.11 | $50.37 | $23.98 |
| Short term investments | $17.65 | $11.92 | $30.34 | $58.18 |
| Net receivables | $3.73 | $2.84 | ||
| Inventory | ||||
| Total current assets | $49.35 | $76.73 | $83.37 | $85.17 |
| Long term investments | ||||
| Property, plant & equipment | $1.11 | $1.58 | $1.88 | $0.24 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.18 | $1.69 | $2.04 | $0.25 |
| Total investments | $17.65 | $11.92 | $30.34 | $58.18 |
| Total assets | $50.53 | $78.42 | $85.41 | $85.43 |
| Current liabilities | ||||
| Accounts payable | $4.71 | $3.98 | $1.23 | $2.77 |
| Deferred revenue | $15.73 | $25.08 | ||
| Short long term debt | $0.44 | $6.12 | $1.8 | $1.67 |
| Total current liabilities | $27.57 | $32.04 | $8.91 | $7.25 |
| Long term debt | $0.38 | $3.24 | $9.98 | $8.28 |
| Total noncurrent liabilities | $0.38 | $14.44 | $9.98 | $8.33 |
| Total debt | $0.82 | $10.19 | $11.79 | $9.94 |
| Total liabilities | $27.96 | $46.48 | $18.9 | $15.57 |
| Shareholders' equity | ||||
| Retained earnings | -$185.74 | -$172.41 | -$109.98 | -$70.92 |
| Other shareholder equity | $0.14 | $0.08 | -$0.14 | -$0.3 |
| Total shareholder equity | $22.57 | $31.94 | $66.5 | $69.85 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9.21 | $8.87 | $9.12 | $8.88 |
| Cost of revenue | ||||
| Gross Profit | $9.21 | $8.87 | $9.12 | $8.88 |
| Operating activities | ||||
| Research & development | $9.18 | $8.97 | $9.61 | $9.27 |
| Selling, general & administrative | $3.23 | $3.52 | $3.1 | $3.71 |
| Total operating expenses | $12.41 | $12.49 | $12.71 | $12.99 |
| Operating income | -$3.2 | -$3.62 | -$3.59 | -$4.11 |
| Income from continuing operations | ||||
| EBIT | -$2.33 | -$3.21 | -$3.08 | -$3.65 |
| Income tax expense | $0.02 | $0.5 | $0.01 | $0.06 |
| Interest expense | $0.26 | $0.23 | ||
| Net income | ||||
| Net income | -$2.34 | -$3.71 | -$3.34 | -$3.94 |
| Income (for common shares) | -$2.34 | -$3.71 | -$3.34 | -$3.94 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $36.08 | $15.76 | ||
| Cost of revenue | ||||
| Gross Profit | $36.08 | $15.76 | ||
| Operating activities | ||||
| Research & development | $37.04 | $37.55 | $26.38 | $19.38 |
| Selling, general & administrative | $13.57 | $17.24 | $11.41 | $10.16 |
| Total operating expenses | $50.61 | $77.55 | $37.54 | $29.55 |
| Operating income | -$14.52 | -$61.8 | -$37.54 | -$29.55 |
| Income from continuing operations | ||||
| EBIT | -$12.26 | -$61.38 | -$37.98 | -$28.71 |
| Income tax expense | $0.58 | |||
| Interest expense | $0.49 | $1.05 | $1.07 | $1.1 |
| Net income | ||||
| Net income | -$13.34 | -$62.43 | -$39.05 | -$29.81 |
| Income (for common shares) | -$13.34 | -$62.43 | -$39.05 | -$29.81 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$2.34 | -$3.71 | -$3.34 | -$3.94 |
| Operating activities | ||||
| Depreciation | $0.03 | $0.03 | $0.03 | $0.03 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.05 | $0.98 | $0.93 | $1.04 |
| Total cash flows from operations | -$5.66 | -$1.91 | -$6.21 | -$8 |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$0.01 | ||
| Investments | -$5.53 | $11 | $15 | -$25.18 |
| Total cash flows from investing | -$5.57 | $10.98 | $15 | -$25.18 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.08 | -$0.26 | $0.09 | |
| Net borrowings | -$7.7 | -$1.43 | ||
| Total cash flows from financing | $0.08 | -$0.26 | -$7.62 | -$1.43 |
| Effect of exchange rate | -$0.01 | -$0.06 | -$0.05 | $0 |
| Change in cash and equivalents | -$11.17 | $8.76 | $1.12 | -$34.6 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$13.34 | -$62.43 | -$39.05 | -$29.81 |
| Operating activities | ||||
| Depreciation | $0.13 | $0.12 | $0.07 | $0.04 |
| Business acquisitions & disposals | $0.7 | |||
| Stock-based compensation | $4 | $4.84 | $4.41 | $3.9 |
| Total cash flows from operations | -$21.78 | -$8.73 | -$32.08 | -$24.62 |
| Investing activities | ||||
| Capital expenditures | -$0.05 | -$0.28 | -$0.06 | -$0.2 |
| Investments | -$4.71 | $18.26 | $27.46 | -$18.39 |
| Total cash flows from investing | -$4.76 | $18.68 | $27.41 | -$18.59 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.1 | $0.21 | $31.06 | $53.95 |
| Net borrowings | -$9.13 | -$1.43 | ||
| Total cash flows from financing | -$9.23 | -$1.22 | $31.06 | $53.95 |
| Effect of exchange rate | -$0.12 | $0.01 | -$0 | $0.03 |
| Change in cash and equivalents | -$35.89 | $8.74 | $26.38 | $10.76 |
News
Fundamentals
| Market cap | $60.99M |
|---|---|
| Enterprise value | $38.60M |
| Shares outstanding | 35.25M |
| Revenue | $36.08M |
|---|---|
| EBITDA | -$12.14M |
| EBIT | -$12.26M |
| Net Income | -$13.34M |
| Revenue Q/Q | -41.55% |
| Revenue Y/Y | 128.97% |
| P/E ratio | -4.57 |
|---|---|
| EV/Sales | 1.07 |
| EV/EBITDA | -3.18 |
| EV/EBIT | -3.15 |
| P/S ratio | 1.69 |
| P/B ratio | 2.72 |
| Book/Share | 0.64 |
| Cash/Share | 0.66 |
| EPS | -$0.38 |
|---|---|
| ROA | -22.57% |
| ROE | -51.82% |
| Debt/Equity | 1.24 |
|---|---|
| Net debt/EBITDA | -0.39 |
| Current ratio | 1.79 |
| Quick ratio | 1.79 |